ORMALVI (dichlorphenamide) by Torrent is carbonic anhydrase inhibitors [moa]. Approved for primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, related variants (). First approved in 2022.
Drug data last refreshed 13h ago
Carbonic Anhydrase Inhibitors
Carbonic Anhydrase Inhibitor
Worked on ORMALVI at Torrent? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.